Multilobar infiltrates are present - The patient is confused or disoriented - Serum urea nitrogen level is >20 mg/dL - WBC \<4,000 cells/mL due to the severity of the infection (not due to other causes such as malignancy or chemotherapy) - Platelet count \<100,000/mL - Core temperature \<36 Â°C - The patient is hypotensive and requires aggressive fluid resuscitation - Major criteria - Patient is in septic shock, requiring vasopressors to maintain adequate mean arterial blood pressure - Patient is in respiratory failure and requires mechanical ventilation Ampicillin/sulbactam, carbapenems, or respiratory fluoroquinolones (such as levofloxacin or moxifloxacin) are effective for most patients with community-acquired aspiration pneumonia.[6] According to the 2019 ATS/IDSA guidelines, for adults without severe pneumonia, significant comorbidities, or risk factors for antibiotic-resistant pathogens in the outpatient setting, any 1 of the following regimens is appropriate:[8] - Amoxicillin 1 g 3 times daily - Doxycycline 100 mg twice daily - A macrolide, such as azithromycin 500 mg on the first day, followed by 250 mg daily or clarithromycin 500 mg twice daily, or clarithromycin extended-release 1,000 mg daily) - Macrolides should only be used in areas where regional pneumococcal resistance to macrolides is \<25%. Patients with comorbidities such as chronic heart disease, chronic liver disease, renal failure, diabetes, chronic lung disease, alcoholism, asplenia, or malignancy with nonsevere pneumonia who are being treated on an outpatient basis the following treatment options are recommended:[8] - Amoxicillin/clavulanate 500 mg/125 mg 3 times daily, 875 mg/125 mg twice daily, or 2,000 mg/125 mg twice daily - A cephalosporin such as cefpodoxime 200 mg twice daily or cefuroxime 500 mg twice daily, combined with a macrolide (as described previously) or doxycycline - A cephalosporin and macrolide combination is preferred. - A respiratory fluoroquinolone such as levofloxacin 750 mg daily, moxifloxacin 400 mg daily, or gemifloxacin 320 mg daily Hospitalized patients with nonsevere CAP, without risk factors for methicillin-resistant _Staphylococcus aureus_ (MRSA) infection or _Pseudomonas aeruginosa_ , may be treated with 1 of the following regimens:[8] - Ampicillin/sulbactam 1.5 to 3 g every 6 hours or cefotaxime 1 to 2 g every 8 hours or ceftriaxone 1 to 2 g daily or ceftaroline 600 mg every 12 hours plus a macrolide (azithromycin 500 mg daily or clarithromycin 500 mg twice daily) - Ampicillin/sulbactam 1.5 to 3 g every 6 hours or cefotaxime 1 to 2 g every 8 hours or ceftriaxone 1 to 2 g